What data powers the Rallies AI report for ENGN?

Rallies AI research for ENGN combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.

Is ENGN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ENGN. It does not provide personalized investment advice.

ENGN (enGene Therapeutics Inc. Common Stock) Stock Analysis - AI Report

enGene Therapeutics Inc. Common Stock (ENGN) is a publicly traded Healthcare sector company. As of May 21, 2026, ENGN trades at $1.55 with a market cap of $105.17M and a P/E ratio of 0.70. ENGN moved +5.88% today. Year to date, ENGN is -81.56%; over the trailing twelve months it is -61.67%. Its 52-week range spans $1.40 to $12.25. Analyst consensus is buy with an average price target of $8.69. Rallies surfaces ENGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on ENGN?

Rallies AI research for ENGN combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

ENGN Key Metrics

Key financial metrics for ENGN
Metric	Value
Price	$1.55
Market Cap	$105.17M
P/E Ratio	0.70
EPS	$2.29
Dividend Yield	0.13%
52-Week High	$12.25
52-Week Low	$1.40
Volume	1.16K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-117.30M
Gross Margin	0.00%

Latest ENGN News

Analysts Slash enGene Price Targets 40% After ENG-1 Trial Misses Endpoints — May 8, 2026
enGene Hits 62% CR in 125-Patient LEGEND Trial, Plans BLA by End-2026 — Feb 28, 2026

Recent ENGN Insider Trades

Forbion Growth Opportunities Fund I Cooperatief U.A. bought 561.80K (~$5.00M) on Oct 30, 2024.
Forbion Growth Opportunities Fund I Cooperatief U.A. bought 800 (~$5.28K) on Oct 8, 2024.
Forbion Growth Opportunities Fund I Cooperatief U.A. bought 11.84K (~$77.53K) on Oct 7, 2024.

ENGN Analyst Consensus

12 analysts cover ENGN: 0 strong buy, 4 buy, 8 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.69.

Common questions about ENGN

What is the AI research view on ENGN?: Rallies AI research for ENGN combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for ENGN?: Rallies AI research for ENGN combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is ENGN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ENGN. It does not provide personalized investment advice.